The stress response and critical illness: A review

被引:62
|
作者
Cuesta, Jeronimo M. [1 ]
Singer, Mervyn [2 ]
机构
[1] N Middlesex Univ Hosp, Dept Intens Care, London N18 1QX, England
[2] UCL, Div Med, Bloomsbury Inst Intens Care Med, London, England
关键词
allostasis; critical illness; homeostasis; mitochondria; resilience; stress; stress response; METABOLIC-RESPONSE; MITOCHONDRIAL-DNA; SEVERE SEPSIS; INJURY; GUIDELINES; DISORDERS; PARADIGM; MEDICINE; SURVIVAL; PROGRESS;
D O I
10.1097/CCM.0b013e31826567eb
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To describe different paradigms that define the stress response, and to postulate how stress is implicated in the pathophysiology of critical illness. Design: Articles were identified through a search of PubMed and Google Scholar. Results: The stress response represents a bundle of adaptive behavioral, physiological, and cellular responses. Although generally beneficial, an important adverse consequence of excessive stress is organ dysfunction. Many interventions currently applied to the critically ill patient are additive and may contribute to organ dysfunction, renewed deterioration, and impaired or delayed recovery. Resilience (rho) summarizes the interaction among predisposition factors, injury (or stressors), and the body's allostatic responses. Resilience changes over the course of critical illness but is potentially measurable and may be used to identify at-risk patients and to tailor therapy. Conclusion: Critical illness may represent a stress-related decompensation syndrome mediated by neural, endocrine, bioenergetic, and immune systems. As patients pass through the separate phases of critical illness, consideration should be given to different therapeutic end points. This may be particularly pertinent during the established organ dysfunction phase where targeting of normal values may have deleterious consequences. Improved strategies could thus emerge from an increased knowledge and monitoring of the stress response, and what constitutes an optimal adaptive state as it evolves in the course of critical illness. (Crit Care Med 2012; 40:3283-3289)
引用
收藏
页码:3283 / 3289
页数:7
相关论文
共 50 条
  • [1] Metabolic response to the stress of critical illness
    Preiser, J. -C.
    Ichai, C.
    Orban, J. -C.
    Groeneveld, A. B. J.
    BRITISH JOURNAL OF ANAESTHESIA, 2014, 113 (06) : 945 - 954
  • [2] Managing stress in critical illness: A question of balance
    Carlson, Drew E.
    CRITICAL CARE MEDICINE, 2012, 40 (12) : 3327 - 3328
  • [3] Stressing the obvious? An allostatic look at critical illness
    Brame, Aimee L.
    Singer, Mervyn
    CRITICAL CARE MEDICINE, 2010, 38 : S600 - S607
  • [4] Mitochondria and Critical Illness
    Supinski, Gerald S.
    Schroder, Elizabeth A.
    Callahan, Leigh Ann
    CHEST, 2020, 157 (02) : 310 - 322
  • [5] Overview of oxidative stress and the role of micronutrients in critical illness
    Dresen, Ellen
    Pimiento, Jose M.
    Patel, Jayshil J.
    Heyland, Daren K.
    Rice, Todd W.
    Stoppe, Christian
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2023, 47 : S38 - S49
  • [6] ERYTHROPOIETIN RESPONSE TO CRITICAL ILLNESS
    KRAFTEJACOBS, B
    LEVETOWN, ML
    BRAY, GL
    RUTTIMANN, UE
    POLLACK, MM
    CRITICAL CARE MEDICINE, 1994, 22 (05) : 821 - 826
  • [7] Sleep and critical illness: a review
    Eschbach, Erin
    Wang, Jing
    FRONTIERS IN MEDICINE, 2023, 10
  • [8] Relationship between stress hyperglycaemic ratio (SHR) and critical illness: a systematic review
    Guoyuan Song
    Xiujuan Liu
    Zihe Lu
    Jingyue Guan
    Xinyue Chen
    Yichen Li
    Gang Liu
    Gang Wang
    Fangfang Ma
    Cardiovascular Diabetology, 24 (1)
  • [9] The HPA axis response to critical illness: New study results with diagnostic and therapeutic implications
    Peeters, B.
    Boonen, E.
    Langouche, L.
    Van den Berghe, G.
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2015, 408 (0C) : 235 - 240
  • [10] Protein C in critical illness
    Mann, Henry J.
    Short, Mary A.
    Schlichting, Douglas E.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (12) : 1089 - 1096